Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
The paper presents the data available in the literature on the efficacy and tolerability of basic tumor necrosis factor α inhibitors (TNF α) etanercept, adalimumab, infliximab in the treatment of psoriatic arthritis (PsA) and their effects on the major manifestations of this disease - cutaneous and...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2010-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | http://mrj.ima-press.net/index.php/mrj/article/view/326 |
Search Result 1